112 related articles for article (PubMed ID: 8020629)
21. Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro.
Volpe DA; Du DL; Verhoef V; Murphy MJ
Pathobiology; 1993; 61(2):77-82. PubMed ID: 8216829
[TBL] [Abstract][Full Text] [Related]
22. The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
Modica-Napolitano JS; Nalbandian R; Kidd ME; Nalbandian A; Nguyen CC
Cancer Lett; 2003 Jul; 198(1):59-68. PubMed ID: 12893431
[TBL] [Abstract][Full Text] [Related]
23. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
Darnowski JW; Davol PA; Goulette FA
Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
[TBL] [Abstract][Full Text] [Related]
24. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
Cretton EM; Xie MY; Bevan RJ; Goudgaon NM; Schinazi RF; Sommadossi JP
Mol Pharmacol; 1991 Feb; 39(2):258-66. PubMed ID: 1996084
[TBL] [Abstract][Full Text] [Related]
25. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
Osman Y; Moriyama Y; Shibata A
Exp Hematol; 1995 May; 23(5):444-52. PubMed ID: 7720816
[TBL] [Abstract][Full Text] [Related]
26. Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
Giallongo C; La Cava P; Tibullo D; Parrinello N; Barbagallo I; Del Fabro V; Stagno F; Conticello C; Romano A; Chiarenza A; Palumbo GA; Di Raimondo F
Eur J Haematol; 2011 Mar; 86(3):216-25. PubMed ID: 21198861
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
[TBL] [Abstract][Full Text] [Related]
28. Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells.
Chitnis S; Mondal D; Agrawal KC
Life Sci; 2002 Jul; 71(8):967-78. PubMed ID: 12084393
[TBL] [Abstract][Full Text] [Related]
29. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
30. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
[TBL] [Abstract][Full Text] [Related]
31. 1,10-phenanthroline potentiates cytotoxicity of hydroxyurea in human chronic myeloid leukemia cells.
Kamath NS; Satyamoorthy K; Chitnis MP; Advani SH
Oncology; 1989; 46(3):193-7. PubMed ID: 2717131
[TBL] [Abstract][Full Text] [Related]
32. Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks.
Andreuccetti M; Allegrini G; Antonuzzo A; Malvaldi G; Conte PF; Danesi R; Del Tacca M; Falcone A
Eur J Cancer; 1996 Jun; 32A(7):1219-26. PubMed ID: 8758257
[TBL] [Abstract][Full Text] [Related]
33. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
34. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Weidner DA; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):797-804. PubMed ID: 2174502
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of interferon-alpha receptor expression in hydroxyurea-treated leukemia cell lines.
Tamura T; Matsuzaki M; Harada H; Ogawa K; Mohri H; Okubo T
J Investig Med; 1997 Apr; 45(4):160-7. PubMed ID: 9154296
[TBL] [Abstract][Full Text] [Related]
36. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
Gallicchio VS; Hughes NK
Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
[TBL] [Abstract][Full Text] [Related]
37. In vitro toxicity of 3'-azido-3'-deoxythymidine, carbovir and 2',3'-didehydro-2',3'-dideoxythymidine to human and murine haematopoietic progenitor cells.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Br J Haematol; 1992 Apr; 80(4):437-45. PubMed ID: 1316140
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of 3'-azido-3'-deoxythymidine incorporation into DNA in human colon tumor cells.
Sharma M; Jain R; Ionescu E; Darnowski JW
Bioconjug Chem; 1995; 6(5):536-40. PubMed ID: 8974451
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
[TBL] [Abstract][Full Text] [Related]
40. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
